SPDR S&P Biotech ETF (NYSEARCA:XBI) Hits New 12-Month High at $103.52

Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $103.52 and last traded at $102.88, with a volume of 5047820 shares. The stock had previously closed at $100.81.

SPDR S&P Biotech ETF Stock Down 0.8 %

The stock’s 50-day moving average is $99.03 and its 200-day moving average is $93.98. The firm has a market cap of $7.74 billion, a P/E ratio of 11.47 and a beta of 1.11.

Institutional Investors Weigh In On SPDR S&P Biotech ETF

Several institutional investors and hedge funds have recently bought and sold shares of XBI. Avoro Capital Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $396,844,000. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 30.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in shares of SPDR S&P Biotech ETF by 1.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after purchasing an additional 18,202 shares during the last quarter. Jane Street Group LLC grew its holdings in shares of SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares during the last quarter. Finally, Bessemer Group Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 1.7% in the 1st quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after purchasing an additional 15,794 shares during the last quarter.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.